Look for:

CELYAD ONCOLOGY SA


ISIN:
BE0974260896
WKN:
-

2022/07/06 17:35:15
Price
1.64 EUR
Difference 4.19% (0.07)

General attributes

ISINBE0974260896
SymbolCYAD
ExchangeEuronext Brussels
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)37 EUR
BenchmarkBEL 20 INDEX

Market data

Bid (Bid size)1.58 EUR (260)
Ask (Ask size)1.64 EUR (869)
Open1.664 EUR
High1.664 EUR
Low1.582 EUR
Close (prev. day)1.574 EUR
VWAP1.65363 EUR
Volume (pcs)2,089
Trading volume3,454.00
Number of trades9
Last size4

Futures and Options

Related Futures-
Related Options-
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2022/07/06 17:35:15
Price
1.64 EUR
Difference 4.19% (0.07)

General attributes

ISINBE0974260896
SymbolCYAD
ExchangeEuronext Brussels
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)37 EUR
BenchmarkBEL 20 INDEX

Market data

Bid (Bid size)1.58 EUR (260)
Ask (Ask size)1.64 EUR (869)
Open1.664 EUR
High1.664 EUR
Low1.582 EUR
Close (prev. day)1.574 EUR
VWAP1.65363 EUR
Volume (pcs)2,089
Trading volume3,454.00
Number of trades9
Last size4

Performance and Risk

6m1y3y
Perf (%)-53.14%-61.82%-85.51%
Perf (abs.)-1.86-2.66-9.68
Beta1.511.260.92
Volatility68.8968.6560.77
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)1.66 EUR (6,544)
Ø price 30 days | Ø volume 30 days (pcs.)1.77 EUR (7,673)
Ø price 100 days | Ø volume 100 days (pcs.)1.99 EUR (27,359)
Ø price 250 days | Ø volume 250 days (pcs.)2.97 EUR (34,750)
YTD High | date3.66 EUR (2022/01/11)
YTD Low | date1.51 EUR (2022/05/18)
52 Weeks High | date4.60 EUR (2021/12/06)
52 Weeks Low | date1.51 EUR (2022/05/18)

Arbitrage views

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Stuttgart2022/07/0613:281.58 EUR0.004
Munich2022/07/0608:031.682 EUR0.002
London Stock Exchange2021/01/2709:066.9303 EUR0.001
Frankfurt2022/07/0608:081.504 EUR0.001
FINRA other OTC Issues2021/12/0817:374.65 USD0.001
Euronext Brussels2022/07/0617:351.64 EUR0.009
Duesseldorf2022/07/0617:011.516 EUR0.0010
Berlin2022/07/0608:031.504 EUR0.001

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=138607&ID_TYPE_IMAGE_LOGO=2

Contact Details

CELYAD ONCOLOGY SA
- -
Axis Business Park - 1435 Mont-Saint-Guibert
Telefon: 32-10-039-41-00
Fax: 32-10-039-41-41
E-mail: info@celyad.com

Company Profile

-

Board of directors

Hilde WindelsChairman of Supervisory Board
Marina UdierMember of Supervisory Board
Rudy DekeyserMember of Supervisory Board
Ami ShahMember of Supervisory Board
Chris BuyseMember of Supervisory Board
Dominic PiscitelliMember of Supervisory Board
Serge GobletMember of Supervisory Board





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. For more details please read our Data protection policy.

INFORMATION FOR CORPORATE AND INSTITUTIONAL CLIENTS

Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).

The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.

Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended). For this reason, the distribution or redistribution of the information, materials and products into United States or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited. The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.

The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.

By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.
(iV) It is no consumer.